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Transformation of Aminoacyl tRNAs
for the In Vitro Selection
of “Drug-like” Molecules
ing libraries that could be made easily by other ap-
proaches. However, ribosome synthesis is critical
because it allows for the encoding of products with
mRNA and the subsequent processing of staggeringly
complex libraries (1013) by in vitro selection [20–25].
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members have the desired function. The basic proce-
dure is to use iterative rounds of selection and amplifica-
tion, where the selective step increases the proportionSummary
of functional molecules and amplification increases their
number. With each round, the library is exponentiallyEvolutionary approaches are regularly used to isolate
enriched in molecules that satisfy the selective criteria.single molecules with desired activities from large
Thus, an originally diverse population that may containpopulations of nucleic acids (1015). Several methods
only a single copy of a desirable molecule quicklyhave also been developed to generate libraries of
evolves into a population dominated by the molecule.mRNA-encoded peptides and proteins for the in vitro
The ribosome-based synthesis of nonstandard poly-selection of functional polypeptides. In principal, such
mers was demonstrated over 30 years ago, and, asmRNA encoding systems could be used with libraries
expected, nonstandard polymers can also be encodedof nonbiological polymers if the ribosome can be di-
with mRNA [23]. Nevertheless, the significant challengerected to polymerize tRNAs carrying unnatural amino
that remains before evolutionary methods can be em-acids. The fundamental problem is that current chemi-
ployed to select novel molecules is the generation of acal aminoacylation systems cannot easily produce suf-
diverse and chemically promising starting population.ficient amounts of the numerous misacylated tRNAs re-
To achieve high diversity with low molecular weight li-quired to synthesize a complex library of encoded
braries that are suitable for drug discovery (M.W.1000;polymers. Here, we show that bulk-aminoacylated
chain length 10), about 20 different building blockstRNA can be transformed into N-monomethylated
(i.e., acylated tRNAs) will be required (10132010). Theaminoacyl tRNA and translated. Because poly-N-methyl
next task, then, is to generate 20 or so nonstandard aa-peptide backbones are refractory to proteases and
tRNAs in sufficient quantity for successive rounds ofare membrane permeable, our method provides an
ribosome-based encoding. Because mRNA encodinguncomplicated means of evolving novel drug candi-
systems produce about 1011 to 1012 library membersdates.
per milliliter, a diverse library of 1013 would require a
translation reaction as large as 100 ml. At normal in
Introduction vitro protein synthesis concentrations (1 mg/ml tRNA),
a considerable amount of tRNA would be necessary
Ribosomes can polymerize well over 100 different amino (10–100 mg). To further complicate matters, current
acid analogs (e.g., [1–5]). As might be predicted from chemical misacylation techniques depend on individu-
surveying the standard 20 amino acids, a wide variety ally isolated tRNAs, separate reactions, multiple steps,
of side chains are acceptable. Perhaps of greater impor- and commercially unavailable reagents [1–5]. Overall,
tance is the fact that unusual backbones can also be this appears to be a cumbersome strategy, even if lower
synthesized by the ribosome. Currently, the list of po- complexity libraries made from small amounts of tRNA
tential translation products includes D-polypeptides, are acceptable. And, while it seems likely that improve-
polyesters, thioesters, thioamides, phosphinoamides, ments in mRNA encoding efficiency as well as optimiza-
-peptides, N-methyl polypeptides, polypeptides with tion of translation reactions will eventually reduce the
quaternary -carbons, hydrazino-based polymers, and total amount of tRNA required, as long as one tRNA is
aminooxy-based polymers [6–13]. Collectively, these consumed for every codon translated (a necessity when
data suggest that ribosomes could be used to synthe- enzymes are not capable of recharging expended tRNAs
size libraries with useful physical, chemical, and biologi- within a translation reaction), library complexity is lim-
cal properties by translating randomized pools of mRNA ited by the amount of nonstandard aa-tRNA that can be
in the presence of tRNAs that bear nonstandard mono- made.
mers (nonstandard aa-tRNAs). For example, poly- An alternative to chemical misacylation is to transform
N-methyl peptides (methylated peptides) seem to be the standard 20 amino acids after they have been
both protease resistant and to have the ability to cross attached to their respective tRNAs by aminoacyl tRNA
cell membranes [14–19], making them an attractive class synthetases. In such an approach, readily available and
of compounds for drug discovery. inexpensive bulk tRNA can be used because the synthe-
By itself, the ribosomal synthesis of nonstandard poly- tases ensure that the correct amino acids are attached
mers is an interesting but rather involved way of generat- to their cognate tRNAs. Subsequent chemical transfor-
mation of the whole population of tRNA-bound amino
acids then allows for the immediate synthesis of 20*Correspondence: ragreen@jhmi.edu
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Figure 1. N-Monomethylation Scheme for
tRNA-Bound Amino Acids
The structures of the reagents are shown above
the arrows, and the aminoacyl tRNA product is
on the right. The aminoacyl tRNA substrate
(aa-tRNA) and RNA chain of tRNA (tRNA) are
abbreviated.
(A) Reductive alkylation with o-nitrobenzalde-
hyde and NaBH3CN produced the monosub-
stituted intermediate N-nitrophenyl amino-
acyl tRNA. The bulky o-nitrobenzaldehyde is
incapable of disubstituting the amino acid
due to steric hinderance [27].
(B) After a brief incubation, formaldehyde was
added directly to the reaction from (A) and
produced the disubstituted intermediate
N-nitrophenyl-N-methyl aminoacyl tRNA.
(C) N-monomethyl aminoacyl tRNA was pro-
duced by photoreversal of the nitrobenzalde-
hyde adduct with UV light.
altered monomers that are ready for translation. Al- methylation) proceeds smoothly ([26]; Figure 1B). In a
final step, the disubstituted intermediate (N-nitrophenyl-though conceptually satisfying with respect to the pro-
duction of nonstandard aa-tRNA in large quantities, this N-methyl aminoacyl tRNA) is exposed to UV light to
remove the protective nitrobenzaldehyde (Figure 1C)framework is subject to a few demanding constraints:
the transformation must ultimately produce polymers and produce the desired tRNA with an N-monomethyl
amino acid.with useful properties; chemical manipulations are con-
fined to reactions that proceed in slightly-acidic-aque- To optimize the chemistry and allow for product analy-
sis, the above scheme was initially applied to puromycin,ous media (the aminoacyl ester bond is base labile and
tRNA is insoluble in common organic solvents); side a minimal analog of aminoacyl tRNA that is chemically
stable and commercially available on the gram scalereactions must not inactivate the 25 kDa tRNAs to which
the amino acids are attached; and nearly quantitative (Figure 2A). As shown by TLC (Figure 2B), reductive
alkylation with nitrobenzaldehyde decreased the mobil-yields are required so that there is a one-to-one corre-
spondence between the monomer borne by a tRNA and ity of puromycin (Figure 2B, compare lanes 1 and 2), and
subsequent addition of formaldehyde to the reactionthe codon the tRNA recognizes.
Here, we show that reductive alkylation with o-nitro- resulted in conversion to the disubstituted intermediate
benzaldehyde followed by reductive methylation with
formaldehyde and photoreversal of the initial adduct
produces tRNAs bearing N-monomethyl amino acids.
This simple transformation is quantitative, and most of
the N-methyl aminoacyl tRNAs are substrates for the
ribosome. Because this approach can be used with bulk
aminoacylated tRNA, it is trivial to simultaneously syn-
thesize large amounts of numerous N-methyl aminoacyl
tRNAs. By eliminating the substantial synthetic efforts
demanded by traditional methods, our approach pro-
vides a readily accessible means for producing and
searching vast libraries (1013) of “drug-like” methylated
peptides via ribosome-based encoding and in vitro se-
lection.
Results
Synthesis of N-Monomethyl Aminoacyl tRNA
The steps used for N-methylation of enzymatically
charged tRNA are outlined in Figure 1. In the first step,
the amino acids were protected from dimethylation by
Figure 2. N-Monomethylation of PuromycinN-alkylating the tRNA-bound amino acids with o-nitro-
(A) Structure of puromycin. The reactive primary amine of the aminobenzaldehyde and sodium cyanoborohydride ([26]; Fig-
acid moiety (methoxytyrosine) is boxed.ure 1A). Although the -amine of the amino acid has the
(B) Synthesis of N-monomethyl puromycin. The products of thepotential to undergo a second alkylation, with nitrobenz-
reaction were separated by TLC, visualized by UV shadowing, and
aldehyde this secondary substitution is sterically pre- photographed. Lane 1, puromycin; lane 2, N-nitrophenyl puromycin;
vented [27]. Upon addition of the less hindered formal- lane 3, N-nitrophenyl-N-methyl puromycin; lane 4, N-methyl puro-
mycin; lane 5, N,N-dimethyl puromycin.dehyde, a second reductive derivatization (this time
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amino acids) when either labeled amino acid or labeled
formaldehyde was used suggested that the desired dou-
ble transformation had occurred (Figure 3A, lanes 4 and
5). When only formaldehyde was used for derivatization,
the dimethylated products were readily identified by
their distinctive mobilities (Figure 3A, lane 3). Finally, as
expected for a nitrophenyl-protected amine, UV expo-
sure shifted the mobilities of the disubstituted intermedi-
ates, and the migrations of the photoreversed products
were distinct from those of the amino acids, intermedi-
ates, or dimethylated controls (Figure 3A, lanes 6 and
7). Again, irrespective of whether the amino acid or form-
aldehyde was labeled, the photoreversed products co-
migrated, consistent with the predicted formation of
N-methyl amino acids. Without hydrolysis, the final
products of the reaction remained at the origin, demon-Figure 3. N-Monomethylation of tRNA-Bound Amino Acids
strating that the chemistry did not cleave the ester link-(A) Synthesis of N-monomethyl- Glu, Ser, and Val. The products and
intermediates of the reaction were separated by TLC and visualized age between the tRNA and N-methyl amino acid (Figure
by phosphorimager analysis. In lanes 2–8, the aminoacyl ester bond 3A, lane 1).
was hydrolyzed to free the modified amino acid from its immobile As a final control, methylation of the tRNA-bound
tRNA. Lane 8 employed bulk tRNA that was charged with a complete
amino acids was verified by comparison to commerciallyamino acid mix and a single radiolabeled amino acid. Lane 1, unhy-
available standards (Figure 3B). Here, the samples weredrolyzed N-methyl [14C]-aminoacyl tRNA; lane 2, [14C]-aminoacyl
analyzed by thin-layer electrophoresis (eTLC) to in-tRNA; lane 3, N,N-dimethyl [14C]-aminoacyl tRNA; lane 4, N-nitro-
phenyl-N-methyl [14C]-aminoacyl tRNA; lane 5, N-nitrophenyl-N-[14C]- crease the resolution between the amino acids and their
methyl aminoacyl tRNA; lane 6, N-methyl [14C]-aminoacyl tRNA; lane N-methyl analogs. Phosphorimager quantitation of the
7, N-[14C]-methyl aminoacyl tRNA; lane 8, N-methyl [14C]-aminoacyl precursors and products indicated that greater than
tRNA from bulk tRNA.
95% of the radiolabeled amino acids were transformed(B) Comigration of N-methyl amino acid standards and transformed
into their N-methyl counterparts (Figure 3B, lanes 1 andamino acids. Radiolabeled N-methyl Glu, Ser, and Val were synthe-
2). Unlabeled standards were cospotted, visualized withsized while bound to their respective tRNA, the aminoacyl-tRNA
ester bond was hydrolyzed, and the samples were mixed with ex- ninhydrin, photographed, and aligned by marks made
cess unlabeled N-methyl-amino acid standards. These mixtures on the thin-layer plates with radiolabeled dyes (Figure
were then subjected to eTLC. Radiolabeled compounds (lanes 1 and 3B, lanes 3 and 4). The N-monomethyl amino acids were
2) were visualized by phosphorimager analysis, and the unlabeled
faintly stained by a modified ninhydrin protocol that al-standards (lanes 3 and 4) were visualized by ninhydrin staining. Lane
lowed for establishment of their mobility (see Experi-1, amino acid; lane 2, N-methyl aminoacyl tRNA; lane 3, unlabeled
mental Procedures).amino acid standard; lane 4, unlabeled N-methyl amino acid
standard.
Transformation of Bulk tRNA
An important aspect of our procedure is its potential to(N-nitrophenyl-N-methyl puromycin; Figure 2B, lane 3).
simultaneously alter many amino acids after a simpleN-monomethyl puromycin was generated by photore-
enzymatic aminoacylation step is used to attach themversal of the disubstituted intermediate (Figure 2B, lane
to their respective tRNAs. By following this methodol-4) and confirmed by mass spectrometry (data not
ogy, the need to purify individual tRNA species andshown). If the protection step was not utilized, formalde-
subsequently subject each tRNA to a multistep misacy-hyde treatment led directly to dimethylation, and this
lation protocol can be avoided. As shown in Figure 3A,product had a distinct mobility (Figure 2B, lane 5).
lane 8, our transformation produced N-methyl aminoNext, to demonstrate the generality of the scheme,
acids from bulk tRNA as readily as from individuallywe performed this chemical transformation on several
purified tRNAs. For these reactions, bulk E. coli tRNAdifferent aminoacyl tRNAs (Glu, Ser, and Val). These
was charged with unlabeled amino acids and the singlediverse amino acids were selected to substantiate that
radiolabeled amino acid of interest. With each of thethe methylation protocol was fundamentally indepen-
amino acids directly tested, N-methyl products weredent of the nature of the side chain. As before, products
efficiently produced, and it seems probable that thefrom each of the individual steps were separated by
remaining 18 N-methyl aminoacyl tRNAs were synthe-TLC (Figure 3A), but the ester linkage to the tRNA was
sized concurrently (proline should return to its originalhydrolyzed before running the TLC to allow direct obser-
form after deprotection).vation of the amino acid moiety. As with puromycin, we
were able to separate the N-methyl products from the
amino acids, disubstituted intermediates, and dimethyl Activity of N-Monomethyl Aminoacyl tRNA
A key requirement for the synthesis of libraries of non-amino acids. Reaction precursors and products were
followed using either labeled amino acids or labeled standard polymers is that the transformed tRNAs be
substrates for the ribosome. This first will depend onformaldehyde, allowing the analysis to establish that
the reaction products contained an amino acid and a the methylation chemistry itself not inactivating the
tRNA body for interaction with the protein synthesisformaldehyde adduct. The equivalent (fast) migration of
the disubstituted intermediates (N-nitrophenyl-N-methyl machinery. Although the standard nucleotides are not
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Figure 5. Peptide Acceptor Activity of tRNA Bearing Methylated Ser
or Val
Ribosomes loaded with mRNA and fMet-tRNAmet were supplied an
N-methyl [14C]-aminoacyl tRNA to form dipeptides (lanes 2 and 4).
Controls lacked the mRNA, and thus no dipeptide was formed (lanes
1 and 3). In lanes 1 and 2, the initiator tRNA was labeled with [35S]-
Met, and before analysis the samples were diluted 100- to 500-
fold to equalize band intensity between [35S]- and [14C]-containing
samples. To show that N-methyl-[14C]amino acids were incorporated
into the dipeptides, lanes 3 and 4 contained unlabeled fMet-tRNAmet.
The amino acids and dipeptide products were separated by eTLC
and visualized by phosphorimager analysis. The fMet (Met) and
Figure 4. Full Activity of Mock-Treated tRNA
N-methyl amino acids (Me) as well as the dipeptide products (Di)
(A) In vitro translation with mock-transformed naked tRNA. As sub- are indicated at right.
strates for translation, ribosomes were supplied untreated bulk tRNA
(lanes 2, 3, 5, and 7) or naked bulk tRNA that had been treated
according to the N-methylation protocol (lanes 4, 6, and 8). Amino- hyde is incorporated into the body of tRNA (i.e., observe
acylation of the tRNAs was performed in the translation mix. Transla-
the radiolabeled formaldehyde which remains at the ori-tion products labeled with [35S]-Met were resolved on a 12% Nu-
gin with tRNA; Figure 3A, lanes 5 and 7), this limitedPAGE gel (Invitrogen) and visualized by phosphorimager analysis.
Lane 1, contained no exogenous tRNA and was incubated for 27 modification has no detectable consequences for tRNA
min; lane 2, contained no mRNA and was incubated for 27 min; function. This is presumably because the modifications
lanes 3 and 4, translation products after 3 min; lanes 5 and 6, prod- are distributed randomly and/or occur at positions that
ucts after 9 min; lanes 7 and 8, products after 27 min. are not critical for overall tRNA function.
(B) Dipeptide formation with mock-treated tRNA. To test the effect
We next asked whether monomethylated Ser and Valof the N-methylation protocol on the tRNA itself, initiation complexes
were effectively incorporated by the ribosome. This wascontaining f-[35S]-Met-tRNAmet and an appropriate mRNA were sup-
plied bulk tRNA that was aminoacylated following a mock treatment. examined by testing the ability of the transformed amino
From left to right, the lanes for each amino acid used normal tRNA acids to form dipeptides encoded by the supplied
or mock-treated tRNA. The dipeptide products were separated by mRNA. Initiation complexes containing fMet-tRNAmet
eTLC and visualized by phosphorimager analysis. Dipeptide (Di) and and the appropriate mRNA were formed, and each of
basic dipeptide (bDi) products are indicated on the right-hand side
the N-methyl aminoacyl tRNAs was added. Productionof the figure.
of fMet-N-methyl dipeptides indicated that the trans-
formed tRNAs were recruited by the ribosome and were
active in peptide bond formation (Figure 5). This docu-expected to undergo reductive alkylation, the potential
for RNA folding to introduce uniquely reactive environ- mentation of activity is important for two reasons. First,
as above, it confirms that chemical transformation doesments and the presence of primary and secondary
amines in the posttranscriptionally modified nucleotides not meaningfully alter the tRNA itself. Second, the pro-
duction of dipeptides that contain labeled N-methylof tRNA suggested that unwanted modifications were
likely. Initial experiments with radiolabeled formalde- amino acids (Figure 5, lane 4) provides clear evidence
that such substrates can be polymerized by the ri-hyde and uncharged tRNA indicated that reductive
methylation resulted in about one undesired modifica- bosome.
To examine the acceptor activity of each of thetion per tRNA. We next performed mock reactions with
deacylated tRNA to examine whether such side reac- N-methyl amino acids, [35S]-Met labeled dipeptides were
produced from initiation complexes that were suppliedtions affected the ability of tRNA to function properly in
translation. As shown in Figure 4A, translation of an 88- bulk tRNA and an appropriate mRNA. The amount of
dipeptide formed when normal tRNA, N-methyl tRNA, oramino acid-long fragment of -galactosidase pro-
ceeded at the same rate and to the same extent with dimethylated tRNA was used as an acceptor substrate is
shown in Figure 6. In general, when compared to theboth treated and untreated tRNA. Furthermore, for each
amino acid, mock-treated tRNA was just as competent amount of dipeptide formed with normal tRNA, the ex-
tent of reaction with N-methylated amino acids wasas untreated tRNA in forming fMet-labeled dipeptides
on the ribosome (Figure 4B). Thus, although formalde- lower but still quite respectable (Figure 6, compare lanes
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Discussion
Here, we demonstrated that a three-step procedure
generated N-monomethylated tRNAs from their amino-
acylated tRNA precursors under mildly acidic, aqueous
conditions. We then established that most of the
N-methylated aminoacyl tRNA substrates had signifi-
cant acceptor activity on the ribosome in peptidyl trans-
ferase assays. As discussed above, this approach is
particularly well suited for synthesizing complex libraries
of methylated peptides due to the ease with which the
nonstandard aa-tRNAs are generated. In conjunction
with ribosome-based encoding schemes, this approach
opens the prospect that methylated peptides with desir-
able functions can be identified by in vitro selection from
diverse populations (1013).
The ribosome-based production of methylated pep-
tides depends on producing nonstandard aa-tRNAs thatFigure 6. Acceptor Activity of Bulk tRNA Bearing N-Monomethyl
reliably incorporate specific N-methyl amino acids inAmino Acids
response to specific codons. Our approach uses tRNAsTranslation initiation complexes containing f-[35S]-Met-tRNAmet and
an appropriate mRNA (see Experimental Procedures) were supplied that are charged by highly accurate synthetases, and
bulk aminoacyl tRNA, and the dipeptides produced were separated thus the expected code (N-methyl Ser at Ser codons,
by eTLC. From left to right, the lanes for each amino acid used etc.) has the potential to be essentially error free. There
normal tRNA, N-methyl tRNA, or N,N-dimethyl tRNA as the acceptor
are, however, mechanisms by which a chemical trans-substrate. The dipeptide (Di) and basic dipeptide (bDi) products are
formation could disrupt the ability of a tRNA to incorpo-indicated at right.
rate the correct monomer into a growing chain. For ex-
ample, incomplete methylation of an amino acid or its
1 and 2). Several amino acids were efficiently incorpo- side chain would result in a degenerate tRNA population
rated (50%; N-methyl- Ala, Phe, His, Ile, Leu and Val), bearing normal and transformed amino acids. Thus,
whereas a number of others were incorporated less well each mRNA sequence would potentially code for a wide
but with an activity of at least 30% in comparison to the variety of mixed polymers rather than a single methyl-
normal amino acid (N-methyl- Cys, Asp, Gly, Met, Gln, ated peptide. This potential problem is exacerbated by
Ser and Thr). Only N-methyl- Glu, Lys, Asn, Arg, and Trp a poorly used N-methyl amino acid, as the unmethylated
were poor substrates (15%). version, even if present at low concentrations, would be
Because product analysis for each of the dipeptide preferentially incorporated by the ribosome. However,
products was not feasible, we used a number of criteria the extent of methylation observed (95%) with three
to establish that the primary product species was au- rather different aminoacyl tRNAs suggests that N-methyla-
thentic. First, in a number of cases, the migration of the tion is quite robust. Furthermore, as no dipeptides are
dipeptide formed with N-methylated tRNA differed from formed from any of the dimethylated tRNAs (Figure 6,
the migration of the dipeptide product formed with un- lane 3), complete alkylation appears to be independent
treated aminoacyl tRNA, which suggested that a methyl of the amino acid, and we therefore expect few problems
group was present and that it altered the mobility of the from untransformed amino acids in the population.
dipeptide (Figure 6; compare lanes 1 and 2 for Ala, His, The efficiency of the peptidyl transferase reaction and
Gln, Ser, and Tyr). Next, we note that N-methyl aminoa- the apparent homogeneity of the dipeptide product var-
cyl tRNAs were almost completely inactive in dipeptide ied across the range of amino acids. In the simplest
formation at conditions where normal tRNA was fully cases, dipeptide products formed from N-methyl-Ala,
functional: normal and mock-treated tRNAs were effi- His, Gln, Ser and Tyr had slightly different mobilities
cient substrates at both low (6 mM) and high (15 mM) than the dipeptides formed from the corresponding un-
magnesium concentration, while the methylated amino- methylated amino acids. These changes in migration
acyl tRNAs were incorporated only at 15 mM magne- are anticipated based on altered chemical properties
sium. Because the transformation procedure has no ef- resulting from the acquisition of a nonpolar methyl
fect on acceptor activity when it is performed before group. The fact that a single product was observed for
bulk tRNA is aminoacylated (Figure 4B), the magnesium these amino acids argues strongly that the product was
dependence and reduced acceptor activity of the tRNAs the N-methylated version of the desired dipeptide. For
when transformation follows aminoacylation must result a second group of amino acids (Asp, Gly, Ile, Leu, Thr,
from derivatization of the amino acids themselves. Fi- and Val), the unmethylated and methylated dipeptide
nally, we established that alkylation was efficient with products migrated similarly. When assayed directly, ra-
each of the amino acids by leaving o-nitrobenzaldehyde diolabeled N-methyl Val was incorporated into dipeptide
out of the transformation reaction (so that the tRNA (Figure 5) and was fully methylated in bulk tRNA (Figure
products carried inactive N,N-dimethyl amino acids) and 3, lane 8). It seems probable that the other dipeptides
showing that no dipeptide was produced from any of also contain N-methyl amino acids, but, like N-methyl
the mRNA templates (Figure 6, lane 3). Thus, it appears Val, their incorporation does not alter the mobility of
their respective product. This idea is supported by thethat all of the amino acids are efficiently alkylated.
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fact that following the methylation protocol, all of the permissive the ribosome is with respect to substitution
at the attacking amine of an amino acid; the experimentsN-methyl amino acids were efficiently incorporated only
when additional Mg2 was supplied to induce productive reported to date required successful competition of the
nonstandard aa-tRNA with release factors, and theinteraction with the ribosome. This condition was unnec-
essary with normal or mock-treated tRNA, and thus the translation systems were not customized for optimal
tRNA loading [11]. Such issues are likely to cause aneffects must result from alteration of the amino acids
themselves. underestimate of substrates acceptable to the ribosome
itself. While increasing the range of available backbonesMultiple dipeptide products were formed from a third
group of modified amino acids (Cys, Phe, and Met), by changing the alkyl substituent on the -amine may
prove challenging, it could provide a powerful meansindicating that there was some miscoding for these co-
don:anticodon pairs. In these cases, while the correct of steering a library toward useful properties such as
extreme protease resistance.N-methylated aminoacyl tRNA appeared to be used,
inappropriate, presumably near-cognate tRNAs were Modification of specific amino acid side chains can
easily extend the properties of our libraries by expandingselected by the ribosome at some rate. Such miscoding
was not wholly unexpected, as the elevated magnesium the range of available monomers. For example, deriva-
tizable side chains such as lysine or cysteine could beconcentrations that were required to recruit N-methyl
aminoacyl tRNAs onto the ribosome are known to de- used to mount diverse groups on normal or suppressor
tRNAs for inclusion within libraries of methylated pep-crease fidelity [28]. It remains possible that the codons
not tested here might exhibit lower levels of miscoding. tides. In previous evolutionary experiments, similar ma-
nipulations have produced peptide-drug conjugatesThese fidelity issues might also be addressed experi-
mentally by further optimization of the reaction condi- whose activity is 100-fold better than the parent com-
pound [32]. With methylated amino acids, the pendanttions. Indeed, when more tRNA was added to these
reactions, the overall level of miscoding decreased (data moieties are mounted on a backbone that has the poten-
tial to enhance the bioavailability and biostability of thenot shown), in agreement with previous results [29]. We
anticipate that during library synthesis with nonstandard parent compound in addition to improving its affinity or
target selectivity. It therefore might prove shrewd toaa-tRNAs, miscoding issues will resurface as translation
irreversibly consumes the preformed tRNAs. It therefore devise selective schemes that are aimed at incorporat-
ing properties that are lacking in existing or abandonedseems possible that library synthesis will require more
nonstandard aa-tRNA than the amount used here (1 mg/ compounds.
ml) for the formation of a single peptide bond. Fortu-
nately, unlike recent methods that propose the use of Significance
chemically charged tRNA [23, 30, 31], our revamped
system can easily supply excess tRNA to limit substrate The technique described in this communication pro-
depletion and the associated problems of miscoding vides a simple chemical approach for transforming
and translation inhibition via the buildup of uncharged bulk aminoacylated tRNA into a pool of N-methylated
tRNA. aminoacyl tRNA for use in in vitro translation reactions.
A final set of amino acids presents us with the greatest Our approach is straightforward and economical (both
challenge. N-methyl- Glu, Lys, Asn, Arg, and Trp were in terms of resources and personnel). These features
inefficiently incorporated by our purified translation sys- should allow for the convenient synthesis of diverse
tem, and we have been unable to increase these values libraries (1013) of methylated peptides. Because such
with any of the standard approaches. This problem will molecules are protease resistant and membrane per-
likely need to be addressed in a different fashion. The meable, the method provides a readily accessible
simplest approach will be to leave the inefficiently incor- means for producing “drug-like” libraries. In conjunc-
porated N-methyl amino acids underivatized in the tRNA tion with ribosome-directed encoding schemes, vast
substrate mix. While we have focused our attention on libraries could be searched by in vitro selection meth-
evaluating the potential to generate universally methyl- ods to ultimately identify inhibitors or modulators of
ated peptides, our method provides the basic tools nec- essentially any target.
essary to generate libraries from combinations of normal
and N-methyl amino acids. Selective methylation can Experimental Procedures
be envisioned by charging bulk tRNA with a subset of
Materialsamino acids; after transformation of these residues, the
Ribosomes, S150 enzyme fraction, aminoacyl-tRNAs, in vitro proteinremaining naked tRNAs would be charged with normal
synthesis reactions, and mRNAs were made and used as previously
amino acids. Because N-methyl amino acids do not ap- described [23]. Individual tRNA species were purchased from Subri-
pear to be removed by the editing function of crude den (Rolling Bay, WA) or Sigma (St. Louis, MO). Radiolabeled amino
aminoacyl tRNA synthetases (data not shown), the sec- acids, amino acid mixtures, and formaldehyde were obtained from
Moravek Biochemicals (Brea, CA), American Radiolabeled Chemi-ond round of aminoacylation should not require purified
cals, (St. Louis, MO) or Sigma. Other materials were purchased fromenzymes.
standard sources.Beyond providing access to libraries of methylated
peptides, our approach might be extended to encom-
Transformation of Puromycinpass other backbones. This could be accomplished by
N-methyl puromycin was synthesized by incubating 8 mM puromy-
using different aldehydes or ketones during the reduc- cin, 50 mM o-nitrobenzaldehyde, and 20 mM cyanoborohydride in
tive alkylation step to add other moieties to the -amine buffer (100 mM NaOAc [pH 5.0], 37C). After 30 min, 0.2 volumes of
100 mM formaldehyde was added to the reaction and the incubationof the aminoacyl tRNAs. Currently, it is unclear how
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continued (ambient; 30 min). The sparingly soluble nitrobenzal- manuscript, and Wes Barfield and Julie Brunelle for the preparation
of numerous reagents. This work was supported by HHMI and thedehyde-puromycin derivatives were purified by centrifugation
(16,000  g; 4C). Precipitates were suspended in ethanol, precipi- NIH.
tated from water, and dissolved in ethanol containing 500 mM BME.
Nitrobenzaldehyde adducts were removed by spotting the sample
Received: January 19, 2004in the cap of a microfuge tube under a covered polystyrene Petri
Revised: February 18, 2004dish, the dish was placed on ice, and the sample was exposed to
Accepted: March 1, 2004UV for 7 min using a 550 watt Hanovia bulb with water jacket [23].
Published online: March 18, 2004Assuming complete recovery, 6 nmol was banded on RP-18 F254
TLC plates (Merck) and developed in 65% acetonitrile (pH 8.0).
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